Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
about
Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions.Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.High variability in glucocorticoid starting doses in patients with rheumatoid arthritis: observational data from an early arthritis cohort.Performance of matrices developed to identify patients with early rheumatoid arthritis with rapid radiographic progression despite methotrexate therapy: an external validation study based on the ESPOIR cohort data.Cardiovascular Comorbidities Relate More than Others with Disease Activity in Rheumatoid ArthritisDiagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis.Methotrexate in combination with other DMARDs is not superior to methotrexate alone for remission induction with moderate-to-high-dose glucocorticoid bridging in early rheumatoid arthritis after 16 weeks of treatment: the CareRA trial.Long-Term Outcomes in Puerto Ricans with Rheumatoid Arthritis (RA) Receiving Early Treatment with Disease-Modifying Anti-Rheumatic Drugs using the American College of Rheumatology Definition of Early RA.Patient-reported Outcomes as Predictors of Change in Disease Activity and Disability in Early Rheumatoid Arthritis: Results from the Yorkshire Early Arthritis Register.Effect of early treatment on physical function in daily management of rheumatoid arthritis: a 5-year longitudinal study of rheumatoid arthritis patients in the National Database of Rheumatic Diseases in Japan.
P2860
Q30249836-C3396632-E102-4FFF-AFB8-47DD078FD82BQ30727631-816F343D-EBB2-45B9-8FB0-9B846FBC4AB4Q30890060-4900D3F7-0851-46E1-A40A-6B3538D6AB59Q31104875-0DBC2E71-49A4-4F0F-AD9C-ED783277E14AQ35891702-B39B1216-6BE1-4967-A94A-AEE1B84E4B1FQ37587406-24A457B5-4127-474B-ACB9-1EFE4CDC5A57Q44640038-D0011C89-6CBB-40B9-8ED9-10D4FFAB71E1Q49243439-91365E6B-F650-443B-9880-08786E538CB5Q50197648-04BCFAC4-90AD-450A-BDBF-62D2F8EBDB63Q53112047-9C1074E6-79A1-4E0E-A635-A821EA1B1277
P2860
Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@ast
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@en
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@nl
type
label
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@ast
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@en
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@nl
prefLabel
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@ast
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@en
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@nl
P2093
P50
P356
P1476
Five-year favorable outcome of ...... : data from the ESPOIR cohort.
@en
P2093
Alain Cantagrel
Bernard Combe
Francis Berenbaum
Francis Guillemin
Isabelle Logeart
Jean Sibilia
Jean-Pierre Daurès
Joelle Benessiano
Nathalie Rincheval
Olivier Meyer
P304
P356
10.3899/JRHEUM.121515
P407
P577
2013-08-15T00:00:00Z